A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

Inclusion Criteria:

Patients with histologically documented diagnosis of one of the following lymphoid malignancies:
Hodgkin Lymphoma;
Mantle Cell Lymphoma;
Indolent Lymphoma (including follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma);
Patients must have received at least one prior treatment regimen; patients with Hodgkin Lymphoma must have received an autologous stem cell transplant, refused or been deemed ineligible for stem cell transplant;
Able to understand and willing to sign the informed consent form.

Exclusion Criteria:

Any histology other than Hodgkin Lymphoma, Mantle Cell Lymphoma or Indolent Lymphoma;
History of or active Central Nervous System (CNS) malignancy;
Active graft-versus-host disease (GVHD);